+44 (0) 20 7549 9987 | USA callers: 00-1-718-682-4567

Contact Us Now

Anti-Ageing Cosmeceuticals Market Set To Grow To $19bn By 2022

14 August 2018
Pharma

Visiongain’ has launched a new pharma report Anti-Ageing Cosmeceuticals 2017-2027: Anti-wrinkle, Anti-stretch Mark, UV Absorbers, Hair, Topical, Invasive, Acne Therapy, Liposuction, Breast Augmentation, Hair Growth, Eyelid Surgery, Botox, Anti-pigmentation, Abdominoplasty, Other Services

Cosmeceuticals are the future generation of cosmetics and personal care industry as they not only improve appearance but also provide necessary nutrients and drug-like properties to the skin. The core properties of cosmeceuticals may be considered as hybrid of traditional cosmetics and medicines or drugs. Technological advancements have resulted in the launch of advanced and more value-added anti-ageing products in the market.

The lead analyst of the report commented “The growth in per capita disposable income, increasing baby boomer population and rising demand in anti-ageing products due to pollution and fluctuating climatic conditions have boosted the growth of anti-ageing cosmeceuticals market. Furthermore, advertisement and promotional activities from companies have strongly influenced the purchasing power and behaviours of consumers.”

Leading companies featured in the report include Allergan PLC, Avon Products Inc.
Beiersdorf AG, Chanel International B.V., Christian Dior SE, Johnson & Johnson, L'ORÉAL S.A., PROCTER & GAMBLE, Revlon Inc., Unilever PLC.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

Read

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

Read

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

Read

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever